Improved rapid detection technologies, novel neuroprotective agents, and targeted anti-inflammatory therapies represent key areas for future R&D investment ... in stroke and neuroprotection research.
Methylene blue, originally a textile dye (synthesized in 1876), has evolved into a medical tool â treating methemoglobinemia, serving as a surgi... .
A novel neuroprotective agent, , has emerged as a promising candidate for treating neurodegenerative disorders, according to recent preclinical research.
MASITINIB SHOWS PROMISING NEUROPROTECTIVE EFFECTS IN NEUROIMMUNE-DRIVEN NEURODEGENERATIVE DISEASE MODEL... NfL is a non-specific marker of axonal loss that can serve as a biomarker of a drug's ability to produce a neuroprotective effect.